Bacteremia is an independent risk factor for mortality in nosocomial pneumonia: a prospective and observational multicenter study
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Introduction: Since positive blood cultures are uncommon in patients with nosocomial pneumonia (NP), the responsible pathogens are usually isolated from respiratory samples. Studies on bacteremia associated with hospital-acquired pneumonia (HAP) have reported fatality rates of up to 50%. The purpose of the study is to compare risk factors, pathogens and outcomes between bacteremic nosocomial pneumonia (B-NP) and nonbacteremic nosocomial pneumonia (NB-NP) episodes. Methods: This is a prospective, observational and multicenter study (27 intensive care units in nine European countries). Consecutive patients requiring invasive mechanical ventilation for an admission diagnosis of pneumonia or on mechanical ventilation for > 48 hours irrespective of admission diagnosis were recruited. Results: A total of 2,436 patients were evaluated; 689 intubated patients presented with NP, 224 of them developed HAP and 465 developed ventilation-acquired pneumonia. Blood samples were extracted in 479 (69.5%) patients, 70 (14.6%) being positive. B-NP patients had higher Simplified Acute Physiology Score (SAPS) II score (51.5 ± 19.8 vs. 46.6 ± 17.5, P = 0.03) and were more frequently medical patients (77.1% vs. 60.4%, P = 0.01). Mortality in the intensive care unit was higher in B-NP patients compared with NB-NP patients (57.1% vs. 33%, P < 0.001). B-NP patients had a more prolonged mean intensive care unit length of stay after pneumonia onset than NB-NP patients (28.5 ± 30.6 vs. 20.5 ± 17.1 days, P = 0.03). Logistic regression analysis confirmed that medical patients (odds ratio (OR) = 5.72, 95% confidence interval (CI) = 1.93 to 16.99, P = 0.002), methicillin-resistant Staphylococcus aureus (MRSA) etiology (OR = 3.42, 95% CI = 1.57 to 5.81, P = 0.01), Acinetobacter baumannii etiology (OR = 4.78, 95% CI = 2.46 to 9.29, P < 0.001) and days of mechanical ventilation (OR = 1.02, 95% CI = 1.01 to 1.03, P < 0.001) were independently associated with B-NP episodes. Bacteremia (OR = 2.01, 95% CI = 1.22 to 3.55, P = 0.008), diagnostic category (medical patients (OR = 3.71, 95% CI = 2.01 to 6.95, P = 0.02) and surgical patients (OR = 2.32, 95% CI = 1.10 to 4.97, P = 0.03)) and higher SAPS II score (OR = 1.02, 95% CI = 1.01 to 1.03, P = 0.008) were independent risk factors for mortality. Conclusions: B-NP episodes are more frequent in patients with medical admission, MRSA and A. baumannii etiology and prolonged mechanical ventilation, and are independently associated with higher mortality rates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the context of pneumonia, as well as other focal infections caused by aerobic Gram-negative bacilli, bacteremia is strongly associated with sepsis and death (13,14).”
From Hepcidin-mediated iron sequestration protects against bacterial dissemination during pneumonia (2017) · cites this paper as [14]
In the citing paper
“We reasoned that the bloodstream dissemination of microorganisms from the primary site of infection is a critical complication in Gram-negative bacterial infections.”
From Hepcidin-mediated iron sequestration protects against bacterial dissemination during pneumonia (2017) · cites this paper as [14]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Vincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674
Le Gall, J.-R. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.270.24.2957 · Cited by 7,773
(2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200405-644st · Cited by 5,877
Fagon, J.-Y., Chastre, J., Hance, A. J., Montravers, P., Novara, A., & Gibert, C. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90060-3 · Cited by 1,180 · cited 1×
“baumannii exhibits an intrinsic resistance to multiple antimicrobial agents and generates a continuing controversy about whether VAP caused by this microorganism increases morbidity and mortality independently of the effect of other confounding factors in the ICU setting [22-25].”
BackgroundVentilator-associated Pneumonia Caused by Potentially Drug-resistant Bacteria
TROUILLET, J.-L., CHASTRE, J., VUAGNAT, A., JOLY-GUILLOU, M.-L., COMBAUX, D., DOMBRET, M.-C., & GIBERT, C. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.2.9705064 · Cited by 885 · cited 1×
“There are several factors linked with MRSA isolation in VAP episodes: administration of antibiotics before the development of VAP [ 29 ,30] and the length of hospital stay rather than the period of mechanical ventilation were strongly associated with MRSA isolation [31].”
BackgroundThe Value of Routine Microbial Investigation in Ventilator-Associated Pneumonia
RELLO, J., GALLEGO, M., MARISCAL, D., SOÑORA, R., & VALLES, J. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.1.9607030 · Cited by 467 · cited 1×
“Since positive blood cultures are uncommon in nosocomial pneumonia (NP) patients, the responsible pathogens are usually isolated from respiratory samples [1-3].”
BackgroundSelf-citationRELLO, J., SA-BORGES, M., CORREA, H., LEAL, S.-R., & BARAIBAR, J. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.2.9812034 · Cited by 352 · cited 2×
“Prior antibiotic exposure was considered when a patient received antimicrobial agents during the 15 days preceding the NP episode, with the exception of antibiotics administered for surgical prophylaxis [13].”
BackgroundSelf-citationNosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment
Cisneros, J. M., & Rodríguez-Baño, J. (2002) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2002.00487.x · Cited by 322 · cited 1×
“baumannii exhibits an intrinsic resistance to multiple antimicrobial agents and generates a continuing controversy about whether VAP caused by this microorganism increases morbidity and mortality independently of the effect of other confounding factors in the ICU setting [22-25].”
Background
Research works printed but not linked: 1
- Menzies BE The role of fibronectin binding proteins in the pathogenesis of Staphylococcus aureus infections Curr Opin Infect Dis 2003 16 225 229 12821812 · DOI · Paper page
Cited by
Chang, Y.-T., Lin, C.-Y., Chen, Y.-H., & Hsueh, P.-R. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00893 · Cited by 419
Nosocomial pneumonia in 27 ICUs in Europe: perspectives from the EU-VAP/CAP study
Koulenti, D., Tsigou, E., & Rello, J. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-016-2703-z · Cited by 392
Self-citationNarrow-spectrum antibacterial agents
Melander, R. J., Zurawski, D. V., & Melander, C. (2018) · MedChemComm · doi:10.1039/c7md00528h · Cited by 226
The lung is a host defense niche for immediate neutrophil-mediated vascular protection
Yipp, B. G., Kim, J. H., Lima, R., Zbytnuik, L. D., Petri, B., Swanlund, N., Ho, M., Szeto, V. G., Tak, T., Koenderman, L., et al. (2017) · Science Immunology · doi:10.1126/sciimmunol.aam8929 · Cited by 213
Pleural innate response activator B cells protect against pneumonia via a GM-CSF-IgM axis
Weber, G. F., Chousterman, B. G., Hilgendorf, I., Robbins, C. S., Theurl, I., Gerhardt, L. M. S., Iwamoto, Y., Quach, T. D., Ali, M., Chen, J. W., et al. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20131471 · Cited by 151
Metadata
- Authors
- Magret, M., Lisboa, T., Martin-Loeches, I., Máñez, R., Nauwynck, M., Wrigge, H., Cardellino, S., Díaz, E., Koulenti, D., Rello, J., & EU-VAP/CAP Study Group
- Affiliations
- Universitat Autònoma de Barcelona (ES)
- Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (ES)
- Bellvitge University Hospital (ES)
- Saint John's Hospital (BE)
- University Hospital Bonn (DE)
- Azienda Sanitaria Locale di Asti (IT)
- Corresponding author
- Rello, Jordi
- Venue
- Critical Care
- Published
- 2011-02-16
- Volume
- 15
- Issue
- 1
- Pages
- R62-R62
- ISSN
- 1364-8535 (ISSN-L)
- PMC
- PMC3221995
- OpenAlex
- W2053637196
- Cited by
- 105
- References
- 37
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 7 · 2023: 6 · 2022: 7 · 2021: 11 · 2020: 5 · 2019: 7 · 2018: 7 · 2017: 14 · 2016: 6 · 2015: 8 · 2014: 8 · 2013: 6 · 2012: 9
- FWCI
- 5.93
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/2.0/ (tdm)
- creativecommons.org/licenses/by/2.0/ (vor)
- Locations
- Critical Care (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RECERCAT (Consorci de Serveis Universitaris de Catalunya) (publishedVersion, other-oa)
- Dipòsit Digital de Documents de la UAB (Universitat Autònoma de Barcelona) (submittedVersion, cc-by)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by)
- Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Epidemiology › Pneumonia and Respiratory Infections
- Keywords
- bacteremia, nosocomial pneumonia, mortality risk factors, ICU mortality, mechanical ventilation, Acinetobacter baumannii, methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa, ICU length of stay, SAPS II score
- MeSH terms
- Aged, Cross Infection, Europe, Female, Humans, Intensive Care Units, Male, Middle Aged, Pneumonia, Prognosis, Prospective Studies, Respiration, Artificial, Risk Factors, Time Factors, Bacteremia, Treatment Outcome, Hospital Mortality, Pneumonia, Bacterial, Acinetobacter baumannii, Methicillin-Resistant Staphylococcus aureus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.